title: Tracking the first major trend in biologics benefit design.
abstract: The migration of specialty drugs from the medical to the pharmacy benefit is gaining momentum. Considering that it is easier to mine utilization and outcomes data from pharmacy claims, such a move is more than just a shell game. How far can it go? How far should it go?
authors: Lola
authors: L
authors: Butcher